Braveheart - now 29.51% shareholders.11 Oct 2024 10:32
Braveheart Investment Group (BRH), announces the acquisition of 65,415,862 ordinary shares in IQ-AI Limited ("IQ-AI"), representing 29.51% of the issued share capital of IQ-AI, for a total consideration of £719,574.48.
The independent directors of Braveheart were offered an opportunity to acquire a substantial stake in IQ-AI. They considered that IB is making progress in its Phase 1 Clinical Trial of gallium maltolate.
The IQ-AI business fits well with Braveheart's investment strategy and will make an attractive addition to Braveheart's investment portfolio at what the board considered is an attractive entry price - ( 1.1p )
GLA . Hopefully we will all be heading upwards !